Liang Zhou

Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody

Tao Dao, Su Yan, Nicholas Veomett et al. · Science Translational Medicine · 2013 · 180 citations

Medicine, Cancer Biology, Oncology +15

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells

Liang Zhou, Yun Zhao, Ashley Ringrose et al. · The Journal of Experimental Medicine · 2008 · 73 citations · Full text

Medicine, Hematology, Oncology +15

Deficiency of SATB1 expression in Sézary cells causes apoptosis resistance by regulating FasL/CD95L transcription

Yang Wang, Mingwan Su, Liang Zhou et al. · Blood · 2011 · 61 citations

Life Sciences, Cell Biology, Molecular Biology +14

Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells

Erin Kennah, Ashley Ringrose, Liang Zhou et al. · Blood · 2009 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +12

Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas

Ashley Ringrose, Youwen Zhou, Emily M. Pang et al. · Leukemia · 2006 · 32 citations

Medicine, Hematology, Oncology +14